♦ Inhibiting the Proliferation of Patient-Derived Glioblastoma Multiforme (GBM) Cells and U-87 MG Cell Line Using Leaf Extract of Bacopa monnieri
» Glioblastoma multiforme (GBM) is the most common, most aggressive, and deadliest form of brain cancer. It has a high mortality rate with few available effective treatment options, and patients have a median survival time ranging only from 7-15 months.
» In this experiment, Tejas produced and applied an extract from Bacopa monnieri, a herbaceous plant he has been performing research on for the past 4 years, onto GBM cells in-vitro. At the end of the study, the results showed that Bacopa actually inhibited the proliferation of these GBM brain tumor cells.
» These results have never before been reported or published. With further research, Bacopa monnieri has the potential to be developed into a novel treatment option for human GBM.
» Experimentation was conducted at Fort Valley State University (Fort Valley, GA) and Karmanos Cancer Institute (Detroit, MI).
» This research project has been presented and discussed at various locations around the world, including universities, non-profit foundations, pharmaceutical companies, international medical and scientific conferences, and other speaking venues.
» This specific body of work has also been recognized by numerous international scientific competitions and organizations.